White label ELPA - ClinicalTrials.eu

Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
Study of Cetuximab and Avelumab for Patients with Recurrent or Metastatic Head and Neck Cancer with PD-L1 Score 1 or Higher

Recruiting

2 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Avelumab
- Cetuximab
Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

Recruiting

3 1 1 1
Investigated diseases:
- Rectal cancer
Investigated drugs:
Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
- Ocrelizumab
- Rituximab
Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Recruiting

3 1 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Nivolumab
- Pembrolizumab
Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

Recruiting

2 1 1 1
Investigated diseases:
- Medulloblastoma
Investigated drugs:
+1
Study on the Use of 68Ga-EVG321 for Diagnosing Small Cell Lung Cancer in Patients

Recruiting

2 1 1
Investigated diseases:
- Small cell lung cancer
Investigated drugs:
- Evg321
- Gallium (68Ga)
Study on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes

Recruiting

3 1 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Dapagliflozin
Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

Recruiting

3 1 1 1
Investigated diseases:
- Antithrombin III deficiency
Investigated drugs:
- Antithrombin Iii Human
- Human Plasma Derived Antithrombin
+2
Study on VSF1.01 for Reducing Surgery Trauma in Hearing Loss Patients Receiving Cochlear Implants

Recruiting

2 1 1
Investigated drugs:
- Vsf1.01

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies